UniXell Biotechnology
UniXell Biotechnology is a Healthcare & Life Sciences startup based in China, most recent round Series A, 1 tracked investor.
About UniXell Biotechnology
UniXell Biotechnology is a company headquartered in China. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
UniXell Biotechnology is a cellular therapy company focused on developing treatments based on human pluripotent stem cells for neurodegenerative diseases, rare diseases, and tumors. The company has developed multiple key technology platforms, including reprogramming, stem cell differentiation, SISBAR pedigree tracing, and high-precision gene editing.
Explore UniXell Biotechnology's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.